dystrophy annihilation research trust · managing director & ceo, andhra med tech zone (amtz)...

4
Date: February 23rd-24th 2018 Venue: The Chancery Pavilion #135, Residency Road, Bangalore – 560 025, INDIA “Current therapeutics and interventions in Duchenne Muscular Dystrophy (DMD)” Diagnosis Awareness Research Therapies Focus on: Dystrophy Annihilation Research Trust Presents 1st International Conference:

Upload: others

Post on 11-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dystrophy Annihilation Research Trust · Managing Director & CEO, Andhra Med Tech Zone (AMTZ) Vishakapatnam Dr.Annemieke Aartsma-Rus Group leader, Leiden University Medical Center

Date: February 23rd-24th 2018 Venue: The Chancery Pavilion

#135, Residency Road, Bangalore – 560 025,     INDIA

“Current therapeutics and interventions in Duchenne Muscular Dystrophy (DMD)”

Diagnosis Awareness Research Therapies

Focus on:

Dystrophy Annihilation Research Trust

Presents

1st International Conference:

Page 2: Dystrophy Annihilation Research Trust · Managing Director & CEO, Andhra Med Tech Zone (AMTZ) Vishakapatnam Dr.Annemieke Aartsma-Rus Group leader, Leiden University Medical Center

Dystrophy Annihilation Research Trust

ABOUT THE CONFERENCE The conference will attract over 500 delegates including Academicians, Patients, Caregivers, Patient Advocacy Organisations, Clinicians and Industry Professionals who will have the platform to: • Network with partners on key issues and challenges in DMD • Engage with panels of international experts who will inform, challenge and stimulate debate • Acquire the latest updates on standards of care, outcome measures, patient registries and new developments

Organising Chairman                    Organising Secretary                         Joint Secretary Mr. Ravdeep Singh Anand                Dr. Arun Shastry                 Dr. Aravind Sankaramoorthy     Hospitality Co-ordinator                       Treasurer                              Conference Co-ordinator  Mr. Berty Ashley                               Ms. Manjula M                           Ms. Keerthi Ramesh

Phone: +91 9840219833         Email: [email protected]           Website: www.dartindia.in

Organising Committee

About Duchenne Muscular Dystrophy

About DART

The Muscular Dystrophies are a group of genetic diseases characterized by progressive weakness and degeneration of the skeletal or voluntary muscles which control movement. The most prevalent and fatal form is Duchenne Muscular Dystrophy which is caused due to a lack of a protein called ‘Dystrophin”. The Disease affects only boys but girls are carriers. One out of 3500 boy is affected and there are around 4,50,000 children suffering from this terrible disease.

Dystrophy Annihilation Research Trust (DART) is a parent-powered NGO founded in 2012, with a mission to create a common platform to provide counselling and support for all Muscular Dystrophy patients and their families, as well as to create awareness of Treatments and Drug Trials, and last but not least, facilitate research into alleviating the scourge of Muscular dystrophy. DART is unique as a parent run Ministry of Science and Technology Govt of India DSIR certified research lab.

Page 3: Dystrophy Annihilation Research Trust · Managing Director & CEO, Andhra Med Tech Zone (AMTZ) Vishakapatnam Dr.Annemieke Aartsma-Rus Group leader, Leiden University Medical Center

Dr. Vijayraghavan K Secretary, Department of Biotechnology (DBT) New Delhi Dr. Geeta Jotwani Deputy Director General, Indian Council of Medical Research (ICMR) New Delhi Dr. Jitendra Kumar Sharma Managing Director & CEO, Andhra Med Tech Zone (AMTZ) Vishakapatnam Dr.Annemieke Aartsma-Rus Group leader, Leiden University Medical Center The Netherlands

Dr. Vijay Chandru Chairman, Strand Life Sciences Bangalore Dr. Jon Andoni Urtizberea Consultant, Assistance publique – Hôpitaux de Paris (AP-HP) Paris Dr. V Viswanathan Paediatric Neurologist, Kanchi Kamakoti Child Trust Hospital Chennai

Ms. Hayley Lethlean Chief Executive Officer Muscular Dystrophy Association of Western Australia (Inc)

Dr. VM Katoch Former DG, ICMR New Delhi

Dr. Meenakshi Bhat Clinical Geneticist, Centre for Human Genetics, Bangalore Dr. V Nagaraja President, Jawaharlal Nehru Centre for Advanced Scientific Research Bangalore

Dr. Upendra Nongthomba Professor, Indian Institute of Science (IISC) Bangalore Dr. Alok Bhattacharya Professor, Jawaharlal Nehru University New Delhi

Dr. Ramprasad VL COO, Medgenome Labs, Bangalore Dr. Roli Mathur Scientist ‘E”, Indian Council of Medical Research (ICMR) New Delhi Dr. Rakesh N Veedu Head, Precision Nucleic Acid Theranostics Group, Murdoch University Australia Dr. Gayathri Narayanappa Professor, National Institute of Mental Health & Neuro Sciences (NIMHANS) Bangalore Dr. Ashwin Dalal Head, Diagnostics, Centre for DNA Fingerprinting and Diagnostics (CDFD) Hyderabad Dr. Surajit Sinha Professor, Indian Association for the Cultivation of Science Kolkata Dr. Shridhar Narayan Director, Foundation for Neglected Disease Research Bangalore

Dr. Namitha Kumar Research Director, The Centre for Health Ecologies and Technology (CHET) Bangalore

Dr. Manju Balasubramanyam Pricipal, Delhi Public School North Bangalore

Dr. Mukesh Jain Project Coordinator, Ayush Muscular Dystrophy Society (AMDS) Bhilai

Mr. Sureshkumar Senior Physiotehrapist, Kanchi Kamakoti Child Trust Hospital Chennai

Speakers

Page 4: Dystrophy Annihilation Research Trust · Managing Director & CEO, Andhra Med Tech Zone (AMTZ) Vishakapatnam Dr.Annemieke Aartsma-Rus Group leader, Leiden University Medical Center

Neuromuscular Diseases Gene-therapy Tissue Engineering Cardiovascular Disease Drug Delivery miRNA and Therapeutics Toxicology

Delegate Registration includes entry to conference, conference material, lunch, and refreshments. Accompanying person includes entry to conference, lunch, and refreshment except conference material.

Delegate – Indian Early Till Dec 31st 2017 Late Jan 1st 2018 – Feb 15th 2018 Spot Commercial / Corporate INR 7,500 INR 10,000 INR 15,000 Academic & Government INR 5,000 INR 7,500 INR 10,000 Student INR 3,500 INR 5,000 INR 7,500 Parent (One Person) INR 3,500 INR 5,000 INR 7,500 Parents (Two Persons) INR 5,000 INR 7,500 INR 10,000 Accompanying Person INR 2,500 INR 3,500 INR 4,500

Delegate – Foreign Early Till Dec 31st 2017 Late Jan 1st 2018 – Feb 15th 2018 Spot Commercial / Corporate USD 770 / INR 50,000 USD 1160 / INR 75,000 USD 1300 / INR 85,000 General USD 460 /INR 5,000 USD 770 / INR 50,000 USD 920 / INR 60,000 Student USD 230 / INR 15,000 USD 385 / INR 25,000 USD 540 / INR 35,000 Accompanying Person USD 150 / INR 10,000 USD 230 / INR 15,000 USD 300 / INR 20,000

Cancellation Policy Cancellation requests can be made by sending an email to [email protected]. Refund is applicable as shown below: Till January 31st 2018 - 50% refund From February 1st 2018 onwards - No refund

Please note refunds will be issued after the conclusion of the meeting by March 31st 2018.

Abstract Categories:

CRISPR Antisense Oligonucleotides Physiotherapy Pharmacology Pharmacokinetics Genomics Proteomics

Scan QR Code to Submit Abstract

# 295 14th Cross Dollars Colony Sanjay Nagar  Bangalore Karnataka 560094 Phone: +91 9840219833         Email: [email protected]           Website: www.dartindia.in

Dystrophy Annihilation Research Trust

@dartindia.in @dartindia7